Richard Chipkin resumes & CV records
Resumes
Richard Chipkin
Location:
Washington D.C. Metro Area
Industry:
Biotechnology
Richard Eric Chipkin, 745266 Pooks Hill Rd, Bethesda, MD 20814
Richard Chipkin Phones & Addresses
5816 Cheshire Dr, Bethesda, MD 20814 301-8978809 301-8978864 301-9192020
Rehoboth Beach, DE
Wethersfield, CT
53 Francisco Ave, Caldwell, NJ 07006 973-2264312
West Caldwell, NJ
Cedar Grove, NJ
Bloomfield, NJ
Mentions for Richard Eric Chipkin
Publications & IP owners
Us Patents
Methods Of Treating Pain And Inflammation With 4,7-Dimethyl-2-(4-Pyridinyl)-1,2,4,-Triazolo[1,5-A]Pyrimidin-5(4H)-One Or The Pharmaceutically Acceptable Salts Or Solvates Thereof
US Patent:
4614743, Sep 30, 1986
Filed:
Dec 27, 1983
Appl. No.:
6/566093
Inventors:
Richard E. Chipkin - Bloomfield NJ
Joseph T. Witkowski - Morris Township, Morris County NJ
Joseph T. Witkowski - Morris Township, Morris County NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31505
C07D48704
C07D48704
US Classification:
514258
Abstract:
The compound 4,7-dimethyl-2-(4-pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidin-5(4H)-one and the pharmaceutically acceptable salts thereof are analgesic and anti-inflammatory agents. Methods for preparing and using the compound and salts are described.
Assay Kit And Methods For Neuroleptic Drugs
US Patent:
5104814, Apr 14, 1992
Filed:
Dec 21, 1990
Appl. No.:
7/631220
Inventors:
Richard Chipkin - West Caldwell NJ
Robert D. McQuade - Scotch Plains NJ
Robert D. McQuade - Scotch Plains NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33567
C07D22316
C07D22316
US Classification:
436504
Abstract:
The invention describes a kit and a method useful for analyzing the plasma concentration of an active neuroleptic drug known to have D-1 receptor antagonist properties utilizing labeled [-]trans 6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H-benzo[d]naphtho-[2 ,1-b]-azepine.
Fused Benzazepines For Treatment Of Stuttering
US Patent:
2016027, Sep 22, 2016
Filed:
Oct 17, 2014
Appl. No.:
15/030271
Inventors:
- Germantown MD, US
Richard E. CHIPKIN - Bethesda MD, US
Richard E. CHIPKIN - Bethesda MD, US
International Classification:
A61K 31/55
A61K 45/06
A61K 9/00
A61K 45/06
A61K 9/00
Abstract:
The present invention encompasses methods of treating a subject who stutters. The methods can include the steps of: (a) identifying a subject in need of treatment; and (b) administering to the subject a therapeutically effective amount of a composition comprising a D1/D5 receptor antagonist, a D1/D5 receptor partial agonist, or a mixture thereof. For example, the D1/D5 receptor antagonist can be ecopipam or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, structural analog, metabolite, or polymorph thereof.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.